If you invest in the stock market, you must know the Dr Reddy share price targets for 2025, 2026, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
DR REDDY operates within the Healthcare sector, specifically in the Drug Manufacturers – Specialty & Generic industries. Listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), Dr. Reddy’s Laboratories Ltd has a significant presence in the Indian stock market.
Dr. Reddy Fundamental Analysis
| Market Cap | ₹1,01,987.13 Cr |
| ROE | 19.54% |
| ROCE | 25.52% |
| P/E | 19.07 |
| P/B | 3.53 |
| Div. Yield | 0.65% |
| Book Value | ₹345.81 |
| Face Value | ₹1 |
| EPS (TTM) | ₹64.11 |
| 52 Week High | ₹1,421.49 |
| 52 Week Low | ₹1,020.00 |
Also Read: Hindalco Share Price Target
Dr. Reddy Share Price Target Tomorrow
Dr Reddy Share Price Target 2025
- Starting Price: ₹1,275
- Mid-Year Price: ₹1,375
- Ending Price: ₹1,480
Dr Reddy Share Price Target 2026
- Starting Price: ₹1,520
- Mid-Year Price: ₹1,580
- Ending Price: ₹1,640
Dr Reddy Share Price Target 2030
- Starting Price: ₹2,280
- Mid-Year Price: ₹2,360
- Ending Price: ₹2,450
Also Read: IndiaMART Share Price Target
Dr Reddy Share Price Target 2040
- Starting Price: ₹5,747
- Mid-Year Price: ₹6,134
- Ending Price: ₹6,946
Dr Reddy Share Price Target 2050
- Starting Price: ₹10,234
- Mid-Year Price: ₹10,412
- Ending Price: ₹10,785
Dr. Reddy Shareholding Pattern
| Retail & Others | 10.45% |
| Promoters | 26.64% |
| Foreign Institutions | 37.29% |
| Mutual Funds | 12.88% |
| Other Domestic Institutions | 12.73% |
Dr. Reddy Key Competitors
Key competitors or peer companies of Dr. Reddy are Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Zydus Lifesciences, Lupin, Aurobindo Pharma, Alkem Laboratories, Glenmark Pharmaceuticals, IPCA Laboratories, and Alembic Pharmaceuticals.
Also Read: PNB Housing Finance Share Price Target
FAQs
Q1: What is the price target for Dr. Reddy in 2025?
A1: The price target for Dr. Reddy in 2025 is projected to range from ₹1,275 to ₹1,480.
Q2: What is the price target for Dr. Reddy in 2030?
A2: The price target for Dr. Reddy in 2030 is projected to range from ₹2,280 to ₹2,450.
Q3: Is Dr. Reddy India a debt-free company?
A3: No, Dr. Reddy is not a debt-free company, because it has debt of ₹792.90 Cr.
Q4: Who is the CEO of Dr. Reddy Laboratories Ltd?
A4: The CEO of Dr. Reddy Laboratories Ltd is Erez Israeli.
We have more than 5 years of experience in stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
